Poll: Pharmas & CMOs Not Moving Fast Enough to Meet Serialization Deadlines
Hundreds attended our recent Serialization Expectations for CMOs webinar to understand how four of the world’s largest pharmaceutical companies — Abbott, Merck KGaA, Sanofi, and Teva — are collaborating with CMOs to achieve compliance and ensure supply.
As they addressed the complexities of technical requirements, onboarding schedules, and choosing a serialization vendor, the message from the four top brands was clear: get going now to avoid the risk of halting supply and driving up costs.
Results from the audience polls taken during the event reveal that while most brands and CMOs believe they’ll be ready by the November 2017 deadline, relatively few have taken the necessary steps to meet that goal.
Here are the top five findings:
1. Most companies say they’ll be ready for serialization.
In all, 9 out of every 10 attendees reported that they will be ready to meet the November 2017 deadline. CMO confidence was slightly higher than brand confidence (91% vs. 87%). It’s clear that brands expect their CMOs to be ready to serialize at operational scale on time. But in order for that to happen, they need to inform CMOs of their requirements for data and choreography before they fall behind.
2. But only 1 in 5 CMOs
know their brand owner requirements.
We know that brand owners expect CMOs to be fully ready by the deadline. But how many brands have shared their requirements with CMOs? Only 1 in 5 CMOs said they know most or all of their brand owner’s requirements for data and choreography. Both parties need to start having conversations right away to ensure compliance readiness.
3. 1 in 3 CMOs haven’t gone beyond initial discussions with customers.
While 1 in 3 CMOs said they’d had initial discussions with their brands, not much is actively happening beyond the “just getting started” stage. Only 1 in 5 CMOs said they understand their customer’s timing requirements.
4. CMOs are behind in line readiness and onboarding.
CMOs need to secure slots in their customer’s onboarding schedule, which 6% said they’ve done. By now, line equipment should have been ordered, though only 14% reported having done so. CMOs should also have the technical requirements from their manufacturers, although only 9% said they’ve received them.
5. Only 1 in 7 CMOs have selected a serialization vendor.
Most CMOs haven’t chosen a serialization provider that will support rapid onboarding of trading partners — one of the most important decisions they can make to ensure readiness.
If you are still getting oriented with your global serialization approach, watch our on-demand webinar to hear four of the world’s top pharma companies share:
- Brand requirements for CMO partners.
- Regulatory considerations in the U.S., EU, and other markets.
- Solution needs and challenges.
- Project and readiness timelines.
- How to integrate with pharma partners.